Study of Gemcitabine and Vinorelbine in Soft Tissue Sarcomas
Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if the combination of gemcitabine and vinorelbine
is effective in treating patients with advanced soft tissue sarcoma.
Phase:
Phase 2
Details
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborators:
Brigham and Women's Hospital Massachusetts General Hospital